Literature DB >> 15213147

Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E.

Colin M Fitzsimmons1, Sarah Joseph, Frances M Jones, Claus M Reimert, Karl F Hoffmann, Francis Kazibwe, Gachuhi Kimani, Joseph K Mwatha, John H Ouma, Edridah M Tukahebwa, Henry C Kariuki, Birgitte J Vennervald, Narcis B Kabatereine, David W Dunne.   

Abstract

Chemotherapy for blood-dwelling schistosomes kills the worms and exposes parasite antigen to the circulation. In many people from areas of endemicity, this treatment increases parasite-specific immunoglobulin E (IgE) and other Th2 responses in the months following therapy, responses that have been associated with subsequent resistance to reinfection. Here we investigate much earlier changes in immune reactions after praziquantel therapy in Schistosoma mansoni-infected fishermen working in an area of high transmission in Uganda. The subjects gave blood before treatment and at 1 and 21 days posttreatment. Blood cultures were incubated with schistosome soluble worm antigen (SWA) or soluble egg antigen (SEA). Interleukin-4 (IL-4), IL-5, IL-10, IL-13, gamma interferon, and transforming growth factor beta levels were measured in the cultures and in plasma. A marked transient increase in plasma IL-5 levels was observed in 75% of the subjects (n = 48) by 1 day posttreatment. This response was dependent on pretreatment intensity of infection and was accompanied by a transient decrease in eosinophil numbers. One day posttreatment, blood cultures from the 16 subjects with the greatest increase in plasma IL-5 level (>100 pg/ml) displayed reduced IL-5, IL-13, and IL-10 responses to SWA, and in contrast to the rest of the cohort, these high-IL-5 subjects displayed reduced levels of SWA-specific IgE in plasma 21 days posttreatment. Twenty months after treatment, the intensity of reinfection was positively correlated with the increase in plasma IL-5 level seen 1 day posttreatment. These studies describe the heterogeneity in early immune reactions to treatment, identifying subgroups who have different patterns of reaction and who may have different capacities to mount the responses that have been associated with resistance to reinfection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213147      PMCID: PMC427444          DOI: 10.1128/IAI.72.7.4023-4030.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

Review 1.  Interleukin-5 and the regulation of eosinophil production.

Authors:  G J Roboz; S Rafii
Journal:  Curr Opin Hematol       Date:  1999-05       Impact factor: 3.284

2.  Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum.

Authors:  Z Zhang; H Wu; S Chen; L Hu; Z Xie; Y Qiu; C Su; J P Cao; Y Wu; S Zhang; G Wu
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Sep-Oct       Impact factor: 2.184

3.  In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. A light and electron microscopic study.

Authors:  H Mehlhorn; B Becker; P Andrews; H Thomas; J K Frenkel
Journal:  Arzneimittelforschung       Date:  1981

4.  Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis.

Authors:  R Gopinath; L E Hanna; V Kumaraswami; V Perumal; V Kavitha; V Vijayasekaran; T B Nutman
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

5.  Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.

Authors:  D W Dunne; A E Butterworth; A J Fulford; H C Kariuki; J G Langley; J H Ouma; A Capron; R J Pierce; R F Sturrock
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

6.  Schistosoma mansoni eggs as a target for praziquantel: efficacy of oral application in mice.

Authors:  M Giboda; J M Smith
Journal:  J Trop Med Hyg       Date:  1994-04

7.  Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.

Authors:  C E Demeure; P Rihet; L Abel; M Ouattara; A Bourgois; A J Dessein
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

Review 8.  Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni.

Authors:  A J Dessein; P Couissinier; C Demeure; P Rihet; S Kohlstaedt; D Carneiro-Carvalho; M Ouattara; V Goudot-Crozel; H Dessein; A Bourgois
Journal:  Immunol Invest       Date:  1992-08       Impact factor: 3.657

9.  Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium.

Authors:  P Hagan; U J Blumenthal; D Dunn; A J Simpson; H A Wilkins
Journal:  Nature       Date:  1991-01-17       Impact factor: 49.962

10.  Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses.

Authors:  A E Butterworth; M Capron; J S Cordingley; P R Dalton; D W Dunne; H C Kariuki; G Kimani; D Koech; M Mugambi; J H Ouma
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

View more
  23 in total

1.  Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel.

Authors:  Claus M Reimert; Colin M Fitzsimmons; Sarah Joseph; Joseph K Mwatha; Frances M Jones; Gachuhi Kimani; Karl F Hoffmann; Mark Booth; Narcis B Kabatereine; David W Dunne; Birgitte J Vennervald
Journal:  Clin Vaccine Immunol       Date:  2006-05

2.  T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment.

Authors:  Kanji Watanabe; Pauline N M Mwinzi; Carla L Black; Erick M O Muok; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  Am J Trop Med Hyg       Date:  2007-10       Impact factor: 2.345

Review 3.  Chronic hepatosplenomegaly in African school children: a common but neglected morbidity associated with schistosomiasis and malaria.

Authors:  Shona Wilson; Birgitte J Vennervald; David W Dunne
Journal:  PLoS Negl Trop Dis       Date:  2011-08-30

4.  Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status.

Authors:  T Milner; L Reilly; N Nausch; N Midzi; T Mduluza; R Maizels; F Mutapi
Journal:  Parasite Immunol       Date:  2010 Nov-Dec       Impact factor: 2.280

5.  Effect of praziquantel treatment during pregnancy on cytokine responses to schistosome antigens: results of a randomized, placebo-controlled trial.

Authors:  Robert Tweyongyere; Patrice A Mawa; Sophy Ngom-Wegi; Juliet Ndibazza; Trinh Duong; Birgitte J Vennervald; David W Dunne; Eli Katunguka-Rwakishaya; Alison M Elliott
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226

6.  Immunoprotection of mice against Schistosomiasis mansoni using solubilized membrane antigens.

Authors:  Guidenn Sulbarán; Oscar Noya; Beatríz Brito; Diana E Ballén; Italo M Cesari
Journal:  PLoS Negl Trop Dis       Date:  2013-06-20

7.  Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis.

Authors:  Claire D Bourke; Norman Nausch; Nadine Rujeni; Laura J Appleby; Kate M Mitchell; Nicholas Midzi; Takafira Mduluza; Francisca Mutapi
Journal:  J Infect Dis       Date:  2012-10-08       Impact factor: 5.226

8.  Cytokine Pattern of T Lymphocytes in Acute Schistosomiasis mansoni Patients following Treated Praziquantel Therapy.

Authors:  Denise Silveira-Lemos; Matheus Fernandes Costa-Silva; Amanda Cardoso de Oliveira Silveira; Mauricio Azevedo Batista; Lúcia Alves Oliveira-Fraga; Alda Maria Soares Silveira; Maria Carolina Barbosa Alvarez; Olindo Assis Martins-Filho; Giovanni Gazzinelli; Rodrigo Corrêa-Oliveira; Andréa Teixeira-Carvalho
Journal:  J Parasitol Res       Date:  2013-01-20

9.  Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils.

Authors:  Shona Wilson; Frances M Jones; Hassan K M Fofana; Aissata Doucouré; Aly Landouré; Gachuhi Kimani; Joseph K Mwatha; Moussa Sacko; Birgitte J Vennervald; David W Dunne
Journal:  PLoS Negl Trop Dis       Date:  2013-03-28

10.  Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trial.

Authors:  Robert Tweyongyere; Patrice A Mawa; Nicholas O Emojong; Harriet Mpairwe; Frances M Jones; Trinh Duong; David W Dunne; Birgitte J Vennervald; Eli Katunguka-Rwakishaya; Alison M Elliott
Journal:  BMC Infect Dis       Date:  2009-03-18       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.